Authors: Balhara YP
PMID: 24380101 [PubMed – indexed for MEDLINE] (Source: Journal of Opioid Management)
Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines.
Previous post: Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocol.
